Relation Between Bone Mineral Density, Gross Motor Function and Quality of Life In Children With Cerebral Palsy

Launched by CAIRO UNIVERSITY · Dec 21, 2023

Keywords

ClinConnect Summary

**Trial Summary: Understanding Bone Health in Children with Cerebral Palsy**

This clinical trial is exploring how bone health, motor skills, and quality of life are connected in children with cerebral palsy (CP). Specifically, the study aims to find out if there is a relationship between bone mineral density (how strong and healthy the bones are), gross motor function (how well children can move), and overall quality of life in children aged 7 to 10 years with CP. By understanding these connections, researchers hope to find ways to help improve bone health and support better physical function in children with different types of motor abilities.

To be eligible for this trial, children must have CP (specifically spastic diplegia or quadriplegia) and be between 7 and 10 years old. They should have a normal body weight and can be at any level of motor function. However, certain conditions would exclude them from the study, such as being underweight or overweight, having specific medical issues, or having had recent fractures. Participants can expect to undergo assessments that will help researchers gather important information about their bone health and physical abilities. Overall, this study aims to provide insights that could lead to better care and interventions for children with cerebral palsy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Children with CP (spastic diplegia and quadriplegia).
• • 2. Their chronological ages will be ranged from 7 to 10 years.
• • 3. They will be selected from both genders.
• • 4. Their motor function will be at any Level according to GMFCS.
• • 5. Their body mass index (BMI ) will be normal.
• • Exclusion criteria
• Children will be excluded from the study if they have any of the following :
• • 1. Underweight, Overweight or Obese.
• • 2. Epilepsy , kidney problems that make them taking hormonal treatments or drugs affect bone density or taking calcium, vitamin D, steroids during 6 months prior to the study.
• • 3. Fracture in the measurement areas.
• • 4. Hip Flexion deformity more than 30° when posed to measure.
• • 5. Internal metallic fixations in the measurement areas (neck of femur and lumber vertebra from L1-L4).
• • 6. Hyperthyroidism or Hypothyroidism.
• • 7. Hypotonia.